DOMVANALIMAB: 58 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
58
Total FAERS Reports
16 (27.6%)
Deaths Reported
56
Hospitalizations
58
As Primary/Secondary Suspect
1
Life-Threatening
First Report: 20230109 · Latest Report: 20241001
What Are the Most Common DOMVANALIMAB Side Effects?
#1 Most Reported
Vomiting
21 reports (36.2%)
#2 Most Reported
Fatigue
20 reports (34.5%)
#3 Most Reported
Dysphagia
20 reports (34.5%)
All DOMVANALIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Vomiting | 21 | 36.2% | 0 | 21 |
| Dysphagia | 20 | 34.5% | 0 | 20 |
| Fatigue | 20 | 34.5% | 0 | 20 |
| Nausea | 17 | 29.3% | 0 | 17 |
| Febrile neutropenia | 8 | 13.8% | 4 | 8 |
| Overdose | 7 | 12.1% | 7 | 7 |
| Asthenia | 6 | 10.3% | 6 | 6 |
| Off label use | 6 | 10.3% | 2 | 6 |
Who Reports DOMVANALIMAB Side Effects? Age & Gender Data
Gender: 14.0% female, 86.0% male. Average age: 70.5 years. Most reports from: ES. View detailed demographics →
Is DOMVANALIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2023 | 27 | 0 | 27 |
| 2024 | 28 | 15 | 28 |
What Is DOMVANALIMAB Used For?
| Indication | Reports |
|---|---|
| Non-small cell lung cancer metastatic | 48 |
Official FDA Label for DOMVANALIMAB
Official prescribing information from the FDA-approved drug label.